Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Invested Capital (2021 - 2025)

Cardio Diagnostics Holdings' Invested Capital history spans 5 years, with the latest figure at $8.2 million for Q3 2025.

  • For Q3 2025, Invested Capital rose 121.14% year-over-year to $8.2 million; the TTM value through Sep 2025 reached $8.2 million, up 121.14%, while the annual FY2024 figure was $9.6 million, 223.1% up from the prior year.
  • Invested Capital for Q3 2025 was $8.2 million at Cardio Diagnostics Holdings, down from $9.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $11.4 million in Q1 2025 and bottomed at $24279.0 in Q3 2021.
  • The 5-year median for Invested Capital is $4.0 million (2022), against an average of $5.2 million.
  • The largest annual shift saw Invested Capital skyrocketed 41112.36% in 2022 before it tumbled 65.28% in 2023.
  • A 5-year view of Invested Capital shows it stood at $1.1 million in 2021, then skyrocketed by 302.74% to $4.3 million in 2022, then tumbled by 31.23% to $3.0 million in 2023, then skyrocketed by 223.1% to $9.6 million in 2024, then fell by 14.71% to $8.2 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Invested Capital are $8.2 million (Q3 2025), $9.7 million (Q2 2025), and $11.4 million (Q1 2025).